Endotoxemia by Porphyromonas Gingivalis Injection Aggravates Non-Alcoholic Fatty Liver Disease, Disrupts Glucose/Lipid Metabolism, and Alters Gut Microbiota in Mice

Frontiers in Microbiology - Switzerland
doi 10.3389/fmicb.2018.02470
Full Text
Abstract

Available in full text

Categories
Microbiology
Date
Authors
Publisher

Frontiers Media SA

Related search

Gut Microbiota and Non-Alcoholic Fatty Liver Disease: New Insights

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2013English

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Phenotyping Non-Alcoholic Fatty Liver Disease by the Gut Microbiota - Ready for Prime Time?

Journal of Gastroenterology and Hepatology
HepatologyGastroenterology
2020English

Involvement of a Periodontal Pathogen, Porphyromonas Gingivalis on the Pathogenesis of Non-Alcoholic Fatty Liver Disease

BMC Gastroenterology
MedicineGastroenterology
2012English

The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease

Children
2017English

Protein Kinase STK25 Aggravates the Severity of Non-Alcoholic Fatty Pancreas Disease in Mice

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2017English

The Regulation Mechanisms of Anthocyanins on Lipid Metabolism in Non-Alcoholic Fatty Liver

Hans Journal of Food and Nutrition Science
2015English

The Effects of Ezetimibe on Non-Alcoholic Fatty Liver Disease and Glucose Metabolism: A Randomised Controlled Trial

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy